|
Issue |
Title |
|
Vol 24, No 2 (2024) |
Adeno-associated virus vector-based gene therapy for hereditary diseases: current problems of application and approaches to solve them |
Abstract
PDF (Rus)
|
T. V. Egorova, A. A. Piskunov, D. A. Poteryaev |
|
Vol 24, No 2 (2024) |
Application of therapeutic nucleic acids and RNA interference to create products for personalised medicine |
Abstract
PDF (Rus)
|
I. P. Shilovskiy, G. B. Pasikhov, V. V. Smirnov, I. A. Kofiadi, M. V. Popova, P. A. Strueva, M. R. Khaitov |
|
Vol 24, No 2 (2024) |
In vivo evaluation of tropism and biodistribution of synthetic and natural adeno-associated viral vectors by next-generation sequencing |
Abstract
PDF (Rus)
|
D. O. Maksimov, D. A. Naumova, E. A. Astakhova, V. V. Artemev, S. A. Biryukov, I. S. Abramov, A. A. Navoikova, N. V. Rudev, S. G. Feoktistova, O. V. Glazova, O. N. Mityaeva, P. Yu. Volchkov |
|
Vol 24, No 2 (2024) |
miRNA-targeting oligonucleotide constructs with various mechanisms of action as effective inhibitors of carcinogenesis |
Abstract
PDF (Rus)
|
S. K. Miroshnichenko, O. A. Patutina, M. A. Zenkova |
|
Vol 24, No 2 (2024) |
Development of recombinant adeno-associated virus empty capsids as a reference standard for quality control of gene therapy products |
Abstract
PDF (Rus)
|
A. V. Tumaev, D. Yu. Voloshin, E. S. Berdinskikh, E. L. Sakhibgaraeva, E. V. Golovin, E. N. Subcheva, O. O. Vasileva, A. A. Galieva, A. A. Chuvashov, E. S. Novikova, A. V. Karabelsky |
|
Vol 24, No 2 (2024) |
Time course of fluorescent-labelled oligonucleotide accumulation in cells with the use of folate receptor-targeted cationic liposomes |
Abstract
PDF (Rus)
|
E. V. Shmendel, O. V. Markov, M. A. Zenkova, M. A. Maslov |
|
Vol 24, No 2 (2024) |
Experience in the production and clinical application of the cell-based medicinal product Easytense® for the repair of cartilage defects of the human knee |
Abstract
PDF (Rus)
PDF (Eng)
|
A. S. Zoricheva, E. A. Zvonova, L. S. Agapova, M. S. Lykova, O. A. Markova, V. S. Leonov |
|
1 - 7 of 7 Items |
|